The Midwestern University Dental Institute, 5855 W. Utopia Road in Glendale, will open its doors 8 a.m.-2 p.m. Saturday, Feb. 1 to provide free dental care and consultations to Valley military veterans.Continue reading→

Finalists will compete in a live pitch competition made up of companies representing four industries: Consumer, Technology, SaaS and Medical for a chance to win a $15,000 cash prize. Each company will advance to the live-demo portion of the contest held Feb 20 at the Tempe Center for the Arts to compete in head-to-head pitches for a chance to win cash and get investor and media exposure. Venture Madness 2020 will opens with a networking reception the night of Feb.19 at Culinary Dropout followed by the one-day pitch event in Tempe. 
Continue reading→

Reglagene, a Tucson-based developer of quadruplex master switch technology that enables the discovery of medicines that control gene expression, placed second in the RESI Innovation Challenge during JPM Week in San Francisco. Hosted by Life Science Nation (LSN), RESI conferences bring together  global early-stage companies across Biotech, Medtech, Diagnostics & Digital Health with life science strategics, family offices, venture funds and angel investors. Continue reading→

Continue reading→

The Healthy Longevity Global Competition, founded by the U.S. National Academy of Medicine and supported by J&J Innovation is a global movement to extend the human healthspan by accelerating research, innovation, and entrepreneurism in healthy longevity. Awards of $50,000 are available. Apply before February 24, 2020.Continue reading→

Tim Becker, an associate professor of practice in the Department of Mechanical Engineering at Northern Arizona University, is developing a polypropylene glycol-based biomaterial called PPODA-QT, which is similar to body tissue, to treat aneurysms in the brain and improve outcomes for stroke and potential stroke patients.Continue reading→

PHOENIX, January 9, 2020 – OncoMyx Therapeutics, a privately-held oncolytic immunotherapy company, announced today the formation of its Scientific Advisory Board (SAB), comprised of experts in tumor immunology, oncology drug discovery and development, and oncolytic viruses. The SAB will work closely with the OncoMyx leadership team as the company advances a therapeutic pipeline of oncolytic immunotherapies based on the myxoma virus (MYXV) platform. The company’s pipeline includes both monotherapies and therapies to be used in combination with immune checkpoint blockade and other immuno-modulatory approaches, offering significant therapeutic promise to a wide range of cancer targets.Continue reading→

On January 1, 2020, President Trump proclaimed January 2020 as National Biotechnology Month.  Continue reading→

With 52  Novel Drug Approvals and 4 Biologic License Application (BLA) approvals, 2019 takes its place as the second most prolific year for approvals in the last two decades.  The record high goes to 2018 with 59 approvals and the record low to 2002 with 17.  (Source)

Read on to see the AZBio Member Companies that  received approvals…

Continue reading→